EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Quantitative Analysis of Locus Coeruleus Neurons and Thalamic Noradrenergic Axons in a Progressive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine Monkey Model of Parkinson's Disease

Megan Carrillo iD, Nagore Hernández-Pinedo iD, Josefa Zaldivar-Diez iD, Isabel Pérez-Santos iD, José A Obeso iD, Carmen Cavada iD, Javier Blesa iD

Movement Disorders · 2026

DOI: 10.1002/mds.70209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Megan Carrillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain. Hauptthemen laut MEDLINE: Locus Coeruleus, Adrenergic Neurons, Axons, Thalamus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Fundación Tatiana Pérez de Guzmán el Bueno, Ministerio de Ciencia, Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease is mainly characterized by dopaminergic neurodegeneration in the substantia nigra pars compacta (SNc) and α‐synuclein accumulation. The locus coeruleus (LC) is also affected in Parkinson's disease and linked to some nonmotor symptoms, but the extent and timing of its degeneration remain unclear. Studies in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)–treated monkeys have reported inconsistent findings ranging from no LC loss to substantial degeneration.

Objectives

We aimed (1) to determine whether noradrenergic neurons and thalamic noradrenergic axons undergo degeneration in a well‐characterized cohort of MPTP‐treated monkeys, and (2) to compare the degree of noradrenergic and dopaminergic loss.

Methods

We performed stereological quantification of noradrenergic neurons in the LC (A5, A6, and A7) and thalamic noradrenergic axons in Macaca fascicularis monkeys (n = 20) representing presymptomatic, recovered, moderate, and severe parkinsonian stages. Noradrenergic neurons and axons were immunostained for dopamine‐β‐hydroxylase, quantified, and compared with previous data from dopaminergic SNc neurons in the same animals.

Results

Noradrenergic cells were largely preserved, with estimated reductions of 4%, 12%, 3%, and 10% in presymptomatic, recovered, moderate, and severe stages, respectively, in parallel with marked and progressive dopaminergic neuronal loss. Densities of noradrenergic axons in the thalamus of MPTP monkeys did not differ significantly from control levels.

Conclusions

We found no evidence of noradrenergic neuronal loss and thalamic noradrenergic axon reduction in MPTP monkeys exhibiting severe SNc damage. These findings show significant differences in vulnerability to MPTP between the dopaminergic and noradrenergic systems. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Locus CoeruleusAdrenergic NeuronsAxonsThalamusMPTP PoisoningParkinsonian DisordersAnimalsMacaca fascicularisDisease Models, AnimalMale1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineFemale

Stichwörter der Autor:innen

Parkinson's diseaselocus coeruleusnon‐human primatesnoradrenalinethalamusvulnerability

Substanzen

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Autor:innen und Institutionen

  • HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
  • Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain.
  • Network Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED), Instituto Carlos III, Madrid, Spain.
  • Department of Anatomy, Histology and Neuroscience, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • PhD Program in Neuroscience Autónoma de Madrid University-Cajal Institute, Madrid, Spain.
  • Centro Universitario HM Hospitales de Ciencias de la Salud (CUHMED), Universidad Camilo José Cela, Madrid, Spain.

ORCID-Profile: Megan Carrillo, Nagore Hernández-Pinedo, Josefa Zaldivar-Diez, Isabel Pérez-Santos, José A Obeso, Carmen Cavada, Javier Blesa

Förderung

  • Instituto de Salud Carlos III
  • Fundación Tatiana Pérez de Guzmán el Bueno
  • Ministerio de Ciencia, Innovación y Universidades

Zitieren

APA

Carrillo, M., Hernández-Pinedo, N., Zaldivar-Diez, J., Pérez-Santos, I., Obeso, J. A., Cavada, C., & Blesa, J. (2026). Quantitative Analysis of Locus Coeruleus Neurons and Thalamic Noradrenergic Axons in a Progressive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine Monkey Model of Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.70209

Vancouver

Carrillo M, Hernández-Pinedo N, Zaldivar-Diez J, Pérez-Santos I, Obeso JA, Cavada C, et al. Quantitative Analysis of Locus Coeruleus Neurons and Thalamic Noradrenergic Axons in a Progressive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine Monkey Model of Parkinson's Disease. Movement Disorders. 2026. doi:10.1002/mds.70209

BibTeX
@article{Carrillo2026,
  author = {Carrillo, Megan and Hernández-Pinedo, Nagore and Zaldivar-Diez, Josefa and Pérez-Santos, Isabel and Obeso, José A and Cavada, Carmen and Blesa, Javier},
  title = {Quantitative Analysis of Locus Coeruleus Neurons and Thalamic Noradrenergic Axons in a Progressive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine Monkey Model of Parkinson's Disease},
  journal = {Movement Disorders},
  year = {2026},
  doi = {10.1002/mds.70209}
}
Kostenlos starten →